We have limited Greek content available. View Greek content.

Jeff Haxer

Partner,

Chicago

Merger & Acquisition (M&A) expert in our Healthcare practice, including pharma, medical devices and insurance

About Jeff

Expertise

  • Expert in our M&A and Healthcare practices
  • Leader of dozens of corporate and PE due diligence assessments, multiple post-merger integration assignments and several complex separations/carve-outs
  • Co-author of Bain's POV on successful spin-offs as published in HBR

Jeff Haxer is the global leader of Bain's Divestitures and Spin-offs product. Previously, he led the M&A group within our Americas Healthcare and Life Sciences practice.

Jeff has led 40+ corporate and PE due diligence assessments, and advised on 25+ acquisition, divestiture, and spin-off transactions with a cumulative value of $200B+.

His industry experience includes pharmaceuticals (small and large molecule), medical devices, healthcare payer, healthcare provider, automotive, insurance, distribution (cold chain and non-cold chain), packaging (rigid and flexible), retail, restaurant and agriculture.

Jeff earned an MBA from the MIT Sloan School of Management and a BBA, with honors, from the University of Michigan.

Recent Insights

Έτοιμοι να μιλήσουμε

Συνεργαζόμαστε με φιλόδοξους ηγέτες που θέλουν να καθορίσουν το μέλλον και όχι. Όχι να κρυφτούν από αυτό. Μαζί, επιτυγχάνουμε πετυχαίνουμε εξαιρετικά αποτελέσματα.